周黑鴨(01458.HK)預期2021年淨利不低於3.3億元
格隆匯3月9日丨 周黑鴨(01458.HK)公吿,根據其對集團截至2021年12月31日止年度未經審核綜合管理賬目的初步評估及董事會目前所得資料,集團預期報吿期間淨利潤不低於人民幣3.3億元,而2020年同期淨利潤為人民幣1.51億元;報吿期間總收入約為人民幣28.7億元,而2020年同期總收入為人民幣21.8億元。
有關增長主要由於後疫情下集團貫徹實施線上線下多元化觸達消費者策略取得了不錯成效,而有關資產處置及投資收益亦對報吿期間淨利潤有所增益。
截至2021年12月31日,集團線下門店總數由2020年底的1755間增加至2781間,互聯網O&O渠道業務於2021年亦取得了顯著增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.